Samarth Kulkarni - 24 Dec 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Executive Officer, Director
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 24 Dec 2024
Transactions value $: $222,904
Form type: 4
Filing time: 27 Dec 2024, 17:35:04 UTC
Previous filing: 04 Dec 2024
Next filing: 19 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise	$223K	+13.8K	+7.57%	$16.21	195K	24 Dec 2024	Direct
holding	CRSP	Common Shares						85.6K	24 Dec 2024	The Kulkarni 2023 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Options Exercise	$0	-13.8K	-100%	$0.00	0	24 Dec 2024	Common Shares	13.8K	$16.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.